Hydrochloric Acid

Hydrochloric Acid

SCHEMBL34133

CC1CN=C(C(C)(C)/N=N/C(C)(C)C2=NCC(C)N2)N1.Cl.Cl

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 3/20 0.33
ADRA2B known ✓ P18089 1/20 0.30
ADRA2C known ✓ P18825 1/20 0.30
NISCH Q9Y2I1 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL957781 1.00 NISCH (0.35) NISCHADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL957782 1.00 NISCH (0.35) NISCHADRA2AADRA2BADRA2C
SCHEMBL346853 0.98 NISCH (0.36) NISCHADRA2AADRA2BADRA2C
SCHEMBL346854 0.98 NISCH (0.36) NISCHADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL8386496 0.96 NISCH (0.33) NISCHADRA2A
SCHEMBL13295932 0.92 NISCH (0.33) NISCH
SCHEMBL7758130 0.79 NISCH (0.39) NISCHADRA2AADRA2BADRA2C
SCHEMBL22462137 0.75 NISCH (0.37) NISCHADRA2AADRA2BADRA2C
SCHEMBL12820853 0.72 NISCH (0.38) NISCHADRA2AADRA2BADRA2C
Carbromal SCHEMBL5013433 0.72 NR3C1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 635 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616473-B1 MIXTURES CONTAINING PHOSPHOROUS, PROCEDURES FOR THEIR PRODUCTION AND USE CLARIANT INT LTD (CH) 2016-11-09 EP claimed
EP-1664746-A4 ANTIOXODANT SENSOR, METHODS AND COMPOSITIONS MANNATECH INC (US) 2009-01-21 EP claimed
JP-2007504443-A 2007-03-01 JP claimed
EP-1697424-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS THE UNIVERSITY OF LEEDS (GB) 2006-09-06 EP claimed
US-7074843-B2 Stability and ejection stability and capable of forming images with fastness, abrasion resistance, color developability, and high density with little feathering SEIKO EPSON CORPORATION (JP) 2006-07-11 US claimed
EP-1664746-A2 ANTIOXODANT SENSOR, METHODS AND COMPOSITIONS Mannatech, Inc. (US) 2006-06-07 EP claimed
WO-2005061555-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS THE UNIVERSITY OF LEEDS (GB) 2005-07-07 WO claimed
WO-2005022116-A2 ANTIOXODANT SENSOR, METHODS AND COMPOSITIONS MANNATECH, INC. (US) 2005-03-10 WO claimed
US-20050038164-A1 Methods and compositions for cementing in well bores HALLIBURTON ENERGY SERVICES, INC 2005-02-17 US claimed
US-20040040714-A1 Methods and compositions for cementing in wellbores HALLIBURTON ENERGY SERVICES, INC. 2004-03-04 US claimed
EP-1394135-A2 Cementing in wellbores Halliburton Energy Services, Inc. (US) 2004-03-03 EP claimed
US-20260125617-A1 TREATMENT FLUID FOR SOFT CONTACT LENS NOF CORPORATION (JP) 2026-05-07 US disclosed
EP-3612303-B1 METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES HAVING AREAS WITH INORGANIC SOLID PARTICLES AND AREAS SUBSTANTIALLY FREE OF INORGANIC SOLID PARTICLES PROCTER & GAMBLE (US) 2026-04-29 EP disclosed
EP-3612304-B1 METHOD FOR MAKING WATER-ABSORBING POLYMER PARTICLES PROCTER & GAMBLE (US) 2026-04-22 EP disclosed
EP-4726006-A1 PRESSURE-SENSITIVE ADHESIVE SHEET Nitto Denko Corporation (JP) 2026-04-15 EP disclosed
US-5260354-A Additives for electrodepositable coating compositions PPG INDUSTRIES, INC. (US) 1993-11-09 US disclosed
WO-1993018099-A1 ADDITIVES FOR ELECTRODEPOSITABLE COATING COMPOSITIONS PPG INDUSTRIES, INC. (US) 1993-09-16 WO disclosed
US-5216074-A Blend of hydrogenated butadiene block polymers, alkenyl aromatic comonomers; acid, hydroxyl, epoxy, amine modified dienes and rubbers JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1993-06-01 US disclosed
EP-0503097-A1 OPTICAL SHEET MATERIAL TORAY INDUSTRIES, INC. (JP) 1992-09-16 EP disclosed
EP-0409580-A2 Thermoplastic elastomer composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125617-A1 TREATMENT FLUID FOR SOFT CONTACT LENS TLN1, CNTN1, PTK2 ADRA2A 4710/4885ADRA2B 4337/4885ADRA2C 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.